The table below shows TANDEM DIABETES CARE INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Revenue
$247.22M
$290.38M
$249.25M
$240.68M
$234.42M
$282.65M
Cost of revenue
$110.43M
-
$114.96M
$114.82M
$116.02M
-
Gross profit
$136.79M
$167.46M
$134.29M
$125.86M
$118.41M
$157.46M
R&D
-
-
-
-
-
-
TNDM annual revenue (10-K history)
TANDEM DIABETES CARE INC reported annual revenue of $1.01B for fiscal year 2025. That is up 7.9% from $940.20M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $84.25M (FY 2016) to $1.01B. Figures come from the company's audited annual reports as filed with the SEC.
